Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
109438-35-9
1148026-98-5
1226767-94-7
1360716-43-3
1446282-41-2
17053-09-7
1628475-90-0 | (3,4)-Cis-1-(tert-butoxycarbonyl)-3-fluoropiperidine-4-carboxylic acid | AA00HYPR | MFCD28016232
1646614-31-4 | 3,5-Dichloro-4-fluorophenylboronic acid | AA00HZ0Z | MFCD18837599
1697878-14-0 | 2-Bromo-5-(pentyloxy)pyridine | AA00HZ9I | MFCD28143958
17216-65-8 | 5-Ethyl-2,2-dimethyl-1,3-dioxane-4,6-dione | AA00HZHO | MFCD00956308
1782769-83-8 | 4-(3-Bromophenyl)-1,2,3-thiadiazol-5-amine | AA00HZQD | MFCD26383428
1802913-21-8 | Tco-peg4-acid | AA00HZYB | MFCD28334565
1807512-38-4 | Carboxyl-peg6-mono-methyl ester | AA00I04M | MFCD28976695
1820587-05-0 | tert-Butyl 1-imino-3,4-dihydroisoquinoline-2-carboxylate | AA00I0CJ | MFCD28101642
1820642-22-5 | Dimethyl 2-(6-chloropyrazin-2-yl)malonate | AA00I0KG | MFCD19689642
1820687-03-3 | 4,6,8-Trichloroquinoline-3-carboxylic acid | AA00I0SK | MFCD28024849